Top Markets
#1 Decred Decred +8.72%
#2 Wibx Wibx +8.37%
#3 Status Status +7.35%
#4 SkyAI SkyAI +5.40%
#5 aelf aelf +5.26%
#6 MarsCoin MarsCoin +5.08%
#7 TRIA TRIA +4.98%
#8 Rei Rei +4.63%
#9 Wrapped Flare Wrapped Flare +4.46%
#10 DexNet DexNet +3.98%
Coin of the day
Decred Decred
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Inhibitor Therapeutics, Inc. Inhibitor Therapeutics, Inc.

Inhibitor Therapeutics, Inc.

INTI
Classifica tra le azioni #30838
Inhibitor Therapeutics, Inc., established in 1992 and based in Tampa, Florida,... Inhibitor Therapeutics, Inc., established in 1992 and based in Tampa, Florida, is a pharmaceutical development enterprise. The company is dedicated to inventing and commercializing medical treatments for patients in the United States who suffer from various cancerous and non-cancerous cell proliferation conditions. A primary focus of their work involves advancing SUBA-Itraconazole, an oral variant of the drug itraconazole, for therapeutic applications in prostate and lung cancers. Furthermore, Inhibitor Therapeutics, Inc. has successfully completed a positive Phase 2b clinical trial for SUBA-Itraconazole in the management of basal cell carcinoma nevus syndrome. The organization was previously known as HedgePath Pharmaceuticals, Inc. until its name was officially changed in August 2019.
Prezzo delle azioni
$0.089
Ultima sincronizzazione: 2026-08-17
Capitalizzazione di mercato
$15.36M
Variazione (1 giorno)
50.59%
Variazione (1 anno)
72.65%
Paese
US
Scambia Inhibitor Therapeutics, Inc. (INTI)

Categoria

Healthcare
Storico del prezzo dell'azione per Inhibitor Therapeutics, Inc. (INTI)
Prezzo di chiusura più alto: $0.08 il 2026-08-01

Prezzo di chiusura più basso: $13.64 il 2003-09-01
Storico del prezzo dell'azione di Inhibitor Therapeutics, Inc. dal 2003 al 2026
Andamento annuale del prezzo dell'azione
Anno Performance
2026 (TTM) 36.93%
2025 -32.43%
2024 -25.17%
2023 28.96%
2022 -48.45%
2021 273.68%
2020 -20.00%
2019 -55.15%
2018 -60.33%
2017 -30.61%
2016 198.81%
2015 -0.18%
2014 51.76%
2013 -99.13%
2004 -21.95%
2003 0.00%
Prezzo dell'azione per aziende simili o concorrenti
Azienda Prezzo dell'azione Variazione 1a% Il paese
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $527.89 35.09%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $996.61 51.72%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $116.42 -20.02%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $735.86 6.07%
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $257.75 14.92%
BE